The recombinant human platelet-derived growth factor type BB (rhPDGF-BB) protein has been approved by FDA for diabetic foot ulcer treatment due to its function of stimulating cell proliferation and wound healing. In this study, the production of rhPDGF-BB from Pichia pastoris is studied in a 7.5 L fermentation using methanol as carbon source and inducer in induction phase. The specific growth rate of the recombinant strain reduced 1.833-fold and rhPDGF-BB productivity reduced 2.13-fold compared to at 0.5 L. To improve growth and protein expression of the strain in induction phase, the mixed feed strategy, in which glycerol or sorbitol was co-fed with methanol at three different molar ratios (1:1, 1:2 and 1:3) was conducted. Using the mixture of glycerol and methanol at the molar ratio 1:2 and the mixture of sorbitol and methanol at the molar ratio 1:3 increased the productivity of rhPDGF-BB protein 1.32-fold (280,48 mg/L) and 1.24-fold (264,15 mg/L), respectively, higher than using only methanol in the induction phase of the fermentation process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.